Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents

Details for Australian Patent Application No. 2002350317 (hide)

Owner MacGregor, A.

Inventors MacGregor, Alexander

Agent Blake Dawson Patent Attorneys

Pub. Number AU-B-2002350317

PCT Number PCT/CA02/01918

PCT Pub. Number WO2003/051333

Priority 10/024,325 14.12.01 US

Filing date 13 December 2002

Wipo publication date 30 June 2003

Acceptance publication date 16 October 2008

International Classifications

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 9/107 (2006.01) Medicinal preparations characterised by special physical form - Emulsions

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 31/195 (2006.01)

A61K 31/34 (2006.01) - having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide

A61K 31/401 (2006.01) - Proline

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/20 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing sulfur

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/02 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 3/14 (2006.01) Drugs for disorders of the metabolism

A61P 5/00 (2006.01) Drugs for disorders of the endocrine system

A61P 7/10 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 7/12 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/08 (2006.01) Drugs for disorders of the respiratory system

A61P 13/00 (2006.01) Drugs for disorders of the urinary system

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 10/024,325 14.12.01 US

28 August 2003 Application Open to Public Inspection

  Published as AU-B-2002350317

16 October 2008 Application Accepted

  Published as AU-B-2002350317

12 February 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002350318-PREPARATION OF IONIC LIQUIDS

2002350316-ADSORPTION OF CONTAMINANTS FROM GASEOUS STREAM AND IN SITU REGENERATION OF SORBENT